Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CSP #2002 - Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes (VA-IMPACT)

NCT02915198 is registered in ClinicalTrials.gov with VA Office of Research and Development as lead sponsor.

NCT NCT02915198
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02915198 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CSP #2002 - Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes (VA-IMPACT)
Lead sponsor
VA Office of Research and Development
Phase
Phase 4
Overall status
Recruiting
Start date
April 3, 2023
Completion date
September 28, 2029
Enrollment
7,410 (estimated)
Sites
40

Conditions

As the registry lists them; a condition with its own page is linked.

atherosclerosis, metformin, prediabetic state